LFASL
VRTX icon

Lugano Financial Advisors SA (LFA)’s Vertex Pharmaceuticals VRTX Stock Holding History

Lugano Financial Advisors SA (LFA)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Hold
23
– – 0.01% 243
2026
Q1 		$10.3K Hold
23
– – 0.01% 209
2025
Q4 		$10.4K Hold
23
– – 0.01% 220
2025
Q3 		$9.01K Hold
23
– – ﹤0.01% 213
2025
Q2 		$10.2K Buy
+23
New +$10.6K 0.01% 213

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Lugano Financial Advisors SA (LFA)'s VRTX Position: Q2 2026 in Review

Lugano Financial Advisors SA (LFA) held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 23 shares worth $11.4K. The position accounts for 0.01% of the portfolio, ranked #243.

Lugano Financial Advisors SA (LFA) first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Lugano Financial Advisors SA (LFA) held 23 shares of Vertex Pharmaceuticals worth $11.4K as of Q2 2026.
  • Lugano Financial Advisors SA (LFA) left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Lugano Financial Advisors SA (LFA)'s portfolio in Q2 2026, its #243 holding.
  • Lugano Financial Advisors SA (LFA) first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q2 2026, filed 28 Jul 2026.